Interact to see
Advertisement
Advertisement
ADNRX vs RRMGX
ADNRX vs RRMGX Comparison
Open Charts ADNRX vs RRMGX
American Beacon ARK Transfmt Innov R6
Price$22.25
Change+$0.70 (+3.25%)
VolumeN/A
Net Assets209.58M
T. Rowe Price Mid-Cap Growth R
Price$91.05
Change+$0.80 (+0.89%)
VolumeN/A
Net Assets25.6B
ADNRX vs RRMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RRMGX commentary
Dec 04, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RRMGX is a Buy.
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 25.6B vs. ADNRX (210M). ADNRX (0.00) and RRMGX (0.00) have matching dividends . ADNRX was incepted earlier than RRMGX: ADNRX (5 years) vs RRMGX (23 years). RRMGX (1.29) is less costly to investors than ADNRX (1.13). ADNRX is a more actively managed with annual turnover of: 46.00 vs. RRMGX (22.60). ADNRX has a lower initial minimum investment than RRMGX: ADNRX (0) vs RRMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 31.21 vs. RRMGX (-12.69). RRMGX return over 5 years is better than : -14.13 vs. ADNRX (-49.08).
| ADNRX | RRMGX | ADNRX / RRMGX | |
| Total Expense Ratio | 1.00 | 1.29 | 78% |
| Annual Report Gross Expense Ratio | 1.13 | 1.29 | 88% |
| Fund Existence | 5 years | 23 years | - |
| Gain YTD | 37.267 | 2.775 | 1,343% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 210M | 25.6B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 31.21 | -12.69 | -246% |
| Returns for 3 years | 88.71 | 3.74 | 2,370% |
| Returns for 5 years | -49.08 | -14.13 | 347% |
| Returns for 10 years | N/A | 16.13 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement